Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- TRV -4.8%, CFG -2.1%, TFC -2.1%, JBHT -1.8%
Other news:
- OMER -4.1% (CHMP reaffirmed its negative opinion on narsoplimab’s European marketing application following re-examination.)
- NFLX -2.6% (Names Peter Rice chief content officer, effective October 26, replacing departing content chief Bela Bajaria.)
- DFH -1.7% (Expects to close its Beazer Homes acquisition Oct. 20 after Beazer stockholders approved the deal.)
- MSB -1.3% (Declares no quarterly distribution, citing lower royalty payments, pending arbitration reserves and supply-chain uncertainty.)
- CNXU -1.3% (Closed a $5 million private placement of 1.67 million units at $3.00 each, including warrants.)
Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- SMTC +4.6%, CNS +2.5%, AA +2.3%, WAFD +1.5%
Other news:
- SITC +18.3% (Declared a $3.00-per-share special cash distribution after selling joint-venture interests for $32.4 million.)
- TSLA +3.5% (Introduces the new Tesla Roadster.)
- VRNS +2.6% (Agreed to be acquired by Proofpoint for $49.75 per share in cash, valuing Varonis at approximately $6.3 billion.)
- INSW +2.6% (Agreed to acquire Bruton for approximately $370 million, adding four VLCCs, as early Q4 spot earnings accelerated.)
- MGNX +2.1% (Dosed the first patient in a Phase 1 study of MGC030 for advanced solid tumors.)
- MMED +1.9% (Named its board after completing its separation from Medtronic and becoming an independent diabetes-focused company.)
- CBIO +1.8% (Completed ASCEND dose escalation for CR-001, with initial monotherapy data expected in Q1 2027.)
- HPP +1.6% (Sold Skyport Plaza for $75.5 million, with proceeds earmarked to reduce its unsecured revolving credit facility.)
Research Calls I
-
Upgrades:
- Avino Silver & Gold Mines (ASM) upgraded to Buy from Neutral at Roth Capital, tgt $7
- Brinker International (EAT) upgraded to Strong Buy from Outperform at Raymond James, tgt $260
- Capri Holdings (CPRI) upgraded to Strong Buy from Outperform at Raymond James, tgt $20
- FEMSA (FMX) upgraded to Overweight from Neutral at JPMorgan, tgt $151
- Fox Corporation (FOXA) upgraded to Buy from Underperform at BofA Securities, tgt $85
- Greif (GEF) upgraded to Outperform from Market Perform at Raymond James, tgt $90
- Semtech (SMTC) upgraded to Outperform from Market Perform at Northland, tgt $186
- Avino Silver & Gold Mines (ASM) upgraded to Buy from Neutral at Roth Capital, tgt $7
-
Downgrades:
- Eastman Chemical (EMN) downgraded to Neutral from Overweight at JPMorgan, tgt $66
- Equifax (EFX) downgraded to Perform from Outperform at Oppenheimer
- FMC (FMC) downgraded to Hold from Buy at Jefferies, tgt $5
- Klaviyo (KVYO) downgraded to Neutral from Buy at Goldman Sachs, tgt $20
- Lloyds Banking Group (LYG) downgraded to Sector Perform from Outperform at RBC Capital
- Melco Resorts (MLCO) downgraded to Hold from Buy at Texas Capital Securities, tgt $5.50
- Workday (WDAY) downgraded to Sector Weight from Overweight at KeyBanc
- Eastman Chemical (EMN) downgraded to Neutral from Overweight at JPMorgan, tgt $66
-
Others:
- ACI Worldwide (ACIW) assumed at Equal Weight at Stephens, tgt $56
- AeroVironment (AVAV) initiated at Outperform at Macquarie, tgt $210
- Arcus Biosciences (RCUS) initiated at Outperform at William Blair
- Bandwidth (BAND) initiated at Equal Weight at Morgan Stanley, tgt $56
- Boot Barn (BOOT) initiated at Buy at Needham, tgt $150
- CACI International (CACI) initiated at Outperform at Macquarie, tgt $780
- CareTrust REIT (CTRE) initiated at Neutral at JPMorgan, tgt $41
- Concentra (CON) initiated at Buy at Jefferies, tgt $47
- Cytokinetics (CYTK) initiated at Outperform at William Blair
- D.R. Horton (DHI) initiated at Hold at StoneX
- EchoStar (ECHO) resumed at Overweight from Underweight at JPMorgan, tgt $144
- Edgewise Therapeutics (EWTX) initiated at Outperform at William Blair
- Eikon Therapeutics (EIKN) initiated at Buy at H.C. Wainwright, tgt $23
- Elanco Animal Health (ELAN) initiated at Buy at Goldman Sachs, tgt $32
- Euronet Worldwide (EEFT) assumed at Equal Weight at Stephens, tgt $71
- Faeth Therapeutics (FTH) initiated at Outperform at William Blair
- Flywire (FLYW) resumed at Equal Weight at Stephens, tgt $20
- FTAI Aviation (FTAI) initiated at Outperform at Macquarie, tgt $305
- Gap (GAP) initiated at Hold at Needham
- Heritage Insurance (HRTG) initiated at Market Perform at Raymond James
- IDEAYA Biosciences (IDYA) initiated at Outperform at William Blair
- IDEXX Laboratories (IDXX) initiated at Buy at Goldman Sachs, tgt $740
- Immunome (IMNM) initiated at Outperform at William Blair
- Intuitive Machines (LUNR) initiated at Outperform at Macquarie, tgt $25
- iRhythm Technologies (IRTC) initiated at Overweight at Piper Sandler, tgt $160
- Kardigan (KARD) initiated at Outperform at William Blair
- Karman Holdings (KRMN) initiated at Outperform at Macquarie, tgt $65
- KB Home (KBH) initiated at Hold at StoneX
- Kontoor Brands (KTB) initiated at Hold at Needham
- Kratos Defense & Security (KTOS) initiated at Outperform at Macquarie, tgt $70
- Moog (MOG.A) assumed at Overweight from Equal Weight at Morgan Stanley, tgt $448
- nCino (NCNO) assumed at Overweight at Stephens, tgt $26
- Palvella Therapeutics (PVLA) initiated at Outperform at William Blair
- Praxis Precision Medicines (PRAX) initiated at Overweight at JPMorgan, tgt $700
- Q2 Holdings (QTWO) assumed at Overweight at Stephens, tgt $74
- Revolution Medicines (RVMD) initiated at Outperform at William Blair
- Rhythm Pharmaceuticals (RYTM) initiated at Outperform at William Blair
- Talen Energy (TLN) initiated at Outperformer at CIBC, tgt $499
- Tango Therapeutics (TNGX) initiated at Outperform at William Blair
- Toll Brothers (TOL) initiated at Buy at StoneX, tgt $165
- Urban Outfitters (URBN) initiated at Buy at Needham, tgt $100
- Victoria's Secret (VSXY) initiated at Buy at Needham, tgt $106
- Wave Life Sciences (WVE) initiated at Outperform at William Blair
- Zoetis (ZTS) initiated at Neutral at Goldman Sachs, tgt $74
- ACI Worldwide (ACIW) assumed at Equal Weight at Stephens, tgt $56
Early premarket gappers
-
Gapping up:
- SITC +18.3%, TSLA +4.4%, SRTA +3.0%, WAFD +2.8%, SMTC +2.6%, AA +2.5%, CNS +2.5%, VRNS +2.3%, MGNX +2.1%, SPCX +2.0%, CBIO +1.8%, HPP +1.6%, INSW +1.6%, NKE +1.6%, IRD +1.2%
-
Gapping down:
- OMER -7.0%, CRWV -4.2%, AVXL -2.0%, RF -1.9%, COIN -1.7%, DFH -1.7%, CFG -1.6%, JBHT -1.4%, MSB -1.3%, CNXU -1.3%, NNI -1.2%
>>> Up
* ABN Amro GDRs Raised to Outperform at KBW; PT 50 euros
* ABN Amro GDRs Raised to Outperform at KBW; PT 50 euros
* Bank of Ireland Raised to Overweight at JPMorgan; PT 21.90 euros
* Bjorn Borg Raised to Buy at Inderes; PT 66 kronor
* Bytes Technology Raised to Neutral at BNP Paribas; PT 470 pence
* Duell Raised to Accumulate at Inderes; PT 2.80 euros (+)
* EchoStar Raised to Overweight at JPMorgan; PT $144
* ING Raised to Outperform at KBW; PT 37.50 euros
* Nestle Raised to Overweight at JPMorgan; PT 100 Swiss francs
* Nordea Bank Raised to Accumulate at Inderes; PT 17 euros (+)
* Schott Pharma Raised to Neutral at BofA; PT 27 euros (+)
* Verbio SE Raised to Buy at Jefferies; PT 42 euros
>>> Down
>>> Down
* AIB Group Cut to Neutral at JPMorgan; PT 12.20 euros
* Barrick Mining Cut to Neutral at CIBC; PT C$69.57
* Eastman Chemical Cut to Neutral at JPMorgan; PT $66
* FMC Corp Cut to Hold at Jefferies; PT $5
* Getlink downgraded to Hold from Buy at Kepler Cheuvreux
* GVS Cut to Neutral at Goldman; PT 6 euros
* Lloyds Cut to Sector Perform at RBC; PT 115 pence
* Siemens Cut to Hold at Jefferies; PT 300 euros
* Siemens Cut to Hold at Jefferies; PT 300 euros
* Varonis Systems Cut to Neutral at DA Davidson; PT $49.75
>>> Initiation
>>> Initiation
* AJ Bell Rated New Hold at Peel Hunt; PT 625 pence
* Constellation Energy Rated New Outperform at CIBC; PT $358
* Cytokinetics Rated New Outperform at William Blair
* EBay Reinstated Buy at William O'Neil
* Humana Rated New Buy at William O'Neil
* Humana Rated New Buy at William O'Neil
* Johnson Matthey Reinstated Buy at Citi; PT 2,850 pence (+)
* Talen Energy Rated New Outperform at CIBC; PT $499
* Telecom Argentina ADRs Reinstated Outperform at Grupo Santander
* Vistra Corp Rated New Outperform at CIBC; PT $201
>>> Call
>>> Call
Strava expands strength training features
A few months ago, Strava announced an overhaul of its strength training experience, with a dedicated workout log for tracking sets, reps, and weights, automatic muscle maps, and more.
Today, the company unveiled new features that build on that, including coach-designed strength workouts that guide users through each exercise with animations, form tips, and information on the targeted muscle groups.
Now, users can track their sets and reps as they go, with the results automatically saved to their activity once the session ends. The muscle maps introduced earlier this year will also update to reflect the completed exercises.
Here’s Strava:
Rolling out to subscribers over the next few weeks, with a sample workout available to free users, the new experience walks athletes through workouts developed by experienced strength coaches with guided animations, and lets them track sets and reps live as they go. Clicking into each exercise also provides guidance on the correct form, tips and the exact muscles targeted. When a workout ends, every exercise, set, and rep is saved directly to the athlete’s activity, and their muscle map updates to show where the effort went.
The company said today’s update also introduces new guided running workouts, with additional workout series planned before the end of the year.
And speaking of what’s coming, Strava says it’s working on a feature that will let users import strength workouts simply by uploading screenshots of training plans or notes containing sets and reps, “as well as a build-your-own workout feature.”